Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture

Strokes of Genius: The Innovation Awards 2018

| Stephanie Sutton

The Medicine Maker 2018 Innovation Awards are here! From colorful capsules, to blockchain software, to high-tech mass spectrometers; we celebrate advances of all stripes and colors.

Business & Regulation

Always the Bridesmaid...

| Gavin Yamey

The pharma industry and research community understands the importance of neglected diseases, but the field is still not receiving the attention it deserves. A new financial modeling tool shows that there is still a major funding gap.

Discovery & Development

Skin Deep Problems

| Maryam Mahdi

A flexible, synthetic patch helps eliminate the toxicity and invasiveness associated with long-term drug delivery

Latest Articles

 Discovery & Development

Spiraling Towards an Answer

| Maryam Mahdi

Researchers capture the interactions of antibodies with the parasite responsible for malaria for the first time
Discovery & Development

Here's to Good Science for 2019

| James Strachan

Successes in the cell and gene therapy field show us that great advances can be made – without taking unnecessary risks.
Business & Regulation

Crossing the Rubicon

| Maryam Mahdi

What does the controversial genome editing work of Jiankui He mean for biomedical research?
Business & Regulation

Withdrawal Symptoms

| James Strachan

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...
Business & Regulation

Business-in-Brief

| Maryam Mahdi

Oscars of science, drug shortage reporting requirements, and a new gene therapy... What’s new for pharma in business?
Discovery & Development

Domesticating Cannabis

| Giovanni Appendino

Tapping into the medical potential of cannabis could transform the future of healthcare.
Manufacture

Back to Basics

| David Walker

David Walker discusses the threat of bioterrorism and the importance of basic research.

Manufacture

A Winning Bid

| Jim Jackson

Emergent Biosolutions, has become a multinational biopharma company, despite working in some difficult therapeutic areas including biodefense.
Manufacture

The Intersection of Infection and Biodefense

| Marcus Horwitz

A single vector vaccine has been developed that could offer protection against tularemia, anthrax, plague and melioidosis.
Manufacture

Rising to the Challenge

| Gary Nabors

How can we prepare ourselves for the threats of emerging infectious disease?
All Articles

Upcoming Events

-

Eye for Pharma

Barcelona, Spain
-

DCAT

New York, USA

CAT Week ‘19: Business Development | Networking | Industry Education
DCAT Week is the premier business development...

 All Events

Sister Publications

You might be interested in our Sister Publications:

Latest White Papers

Effective Removal of mAb Aggregate Using Ca++Pure-HA® Media with Potassium Salts

| Contributed by Tosoh

Protein stability analysis technologies for the biopharmaceutical industry

| Contributed by Malvern Panalytical

Technology for combating counterfeit medicine

| Contributed by Malvern Panalytical

Toothpaste identification by FingerPrint

| Contributed by Malvern Panalytical

All White Papers

Webinars on Demand

Discovery & Development

Rapid, Automated Peptide Mapping for Multi Attribute Monitoring

| Sponsored by ThermoFisher Scientific

This webcast details how new technologies can deliver peptide mapping.
Discovery & Development

Assessing Critical Quality Attributes and Structural Conformation of Biotherapeutics by HDX-MS

| Sponsored by ThermoFisher Scientific

Join the webinar to hear how advanced ionisation techniques give additional structural insights into protein conformation.
Business & Regulation

Cell Therapy Facilities – Designing for Flexibility, Scalability, and Cost Effectiveness

| Sponsored by CRB

The webinar will provide an introduction to the design issues for Cell Therapy Facilities.
All Webinars

Most popular articles

1. Manufacture

Strokes of Genius: The Innovation Awards 2018

| Stephanie Sutton

The 2018 Innovation Awards are here! From capsules, to software, to high-tech mass spectrometers; we celebrate the advances of the field.

2. Business & Regulation

Withdrawal Symptoms

| James Strachan

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...
3. Business & Regulation

Always the Bridesmaid...

| Gavin Yamey

The pharma industry understands the importance of neglected diseases, but the field is still not receiving the attention it deserves.

4. Discovery & Development

Domesticating Cannabis

| Giovanni Appendino

Tapping into the medical potential of cannabis could transform the future of healthcare.
5. Discovery & Development

Here's to Good Science for 2019

| James Strachan

Successes in the cell and gene therapy field show us that great advances can be made – without taking unnecessary risks.

Discovery & Development

Skin Deep Problems

| Maryam Mahdi

A flexible, synthetic patch helps eliminate the toxicity and invasiveness associated with long-term drug delivery

Spiraling Towards an Answer

| Maryam Mahdi

Researchers capture the interactions of antibodies with the parasite responsible for malaria for the first time

Here's to Good Science for 2019

| James Strachan

Successes in the cell and gene therapy field show us that great advances can be made – without taking unnecessary risks.

Manufacture

Strokes of Genius: The Innovation Awards 2018

| Stephanie Sutton

The 2018 Innovation Awards are here! From capsules, to software, to high-tech mass spectrometers; we celebrate the advances of the field.

Back to Basics

| David Walker

David Walker discusses the threat of bioterrorism and the importance of basic research.

A Winning Bid

| Jim Jackson

Emergent Biosolutions, has become a multinational biopharma company, despite working in some difficult therapeutic areas including biodefense.

Business & Regulation

Always the Bridesmaid...

| Gavin Yamey

The pharma industry understands the importance of neglected diseases, but the field is still not receiving the attention it deserves.

Crossing the Rubicon

| Maryam Mahdi

What does the controversial genome editing work of Jiankui He mean for biomedical research?

Withdrawal Symptoms

| James Strachan

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker